We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$118M
This Fund
S&P 500
This Quarter
Est. Return
-5.2%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
-$3.89M
(-2.2%)
Cap. Flow
+$11.2M
Cap. Flow
% of AUM
6.35%
Top 10 Holdings %
Top 10 Hldgs %
22.1%
Holding
256
New
24
Increased
39
Reduced
133
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.86M |
| 2 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$3.65M |
| 3 |
TSVT
2seventy bio
TSVT
|
+$3.13M |
| 4 |
uniQure
QURE
|
+$3.1M |
| 5 |
Embecta
EMBC
|
+$2.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AdaptHealth
AHCO
|
+$3.44M |
| 2 |
Elanco Animal Health
ELAN
|
+$2.97M |
| 3 |
Centene
CNC
|
+$2.7M |
| 4 |
iShares MBS ETF
MBB
|
+$2.05M |
| 5 |
Lantheus
LNTH
|
+$1.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 61.71% |
| 2 | Real Estate | 10.29% |
| 3 | Financials | 3.55% |
| 4 | Technology | 3.29% |
| 5 | Energy | 2.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Jabil
JBL
$32.8B
| $116K | 0.07% |
918
-155
| -14% | -$17K |
|
177
American International
AIG
$41.9B
| $115K | 0.07% |
1,902
-190
| -9% | -$11.3K |
|
178
Ford
F
$57.3B
| $114K | 0.06% |
9,201
-877
| -9% | -$11.4K |
|
179
iShares MSCI Austria ETF
EWO
$146M
| $110K | 0.06% |
5,606
-699
| -11% | -$14.2K |
|
180
Apollo Global Management
APO
$70.7B
| $108K | 0.06% |
1,207
-199
| -14% | -$16.7K |
|
181
Lennar Class A
LEN
$20.4B
| $108K | 0.06% |
990
-5,131
| -84% | -$602K |
|
182
iShares MSCI France ETF
EWQ
$324M
| $107K | 0.06% |
3,012
-336
| -10% | -$12.6K |
|
183
Everest Group
EG
$15.2B
| $107K | 0.06% |
287
-30
| -9% | -$10.9K |
|
184
Hartford Financial Services
HIG
$38.5B
| $106K | 0.06% |
1,496
-151
| -9% | -$11K |
|
185
General Motors
GM
$74.7B
| $106K | 0.06% |
3,211
-335
| -9% | -$11.9K |
|
186
Imperial Oil
IMO
$62.1B
| $103K | 0.06% |
1,671
-272
| -14% | -$14.9K |
|
187
Canadian Natural Resources
CNQ
$96.9B
| $103K | 0.06% |
3,172
-496
| -14% | -$15.2K |
|
188
CF Industries
CF
$19.2B
| $98.6K | 0.06% |
1,150
-118
| -9% | -$9.32K |
|
189
Archer Daniels Midland
ADM
$41.4B
| $97.3K | 0.06% |
1,290
-130
| -9% | -$10.5K |
|
190
Star Holdings Shares of Beneficial Interest
STHO
$112M
| $97K | 0.06% |
7,744
| – | – |
|
191
HF Sinclair
DINO
$15.9B
| $96.7K | 0.05% |
1,699
-275
| -14% | -$14.9K |
|
192
Arch Capital
ACGL
$36.1B
| $96.1K | 0.05% |
1,206
-206
| -15% | -$16K |
|
193
HCA Healthcare
HCA
$84.8B
| $95.9K | 0.05% |
390
-41
| -10% | -$11.2K |
|
194
iShares MSCI South Korea ETF
EWY
$21.7B
| $95.1K | 0.05% |
1,613
-607
| -27% | -$38.5K |
|
195
Principal Financial Group
PFG
$23.6B
| $94.3K | 0.05% |
1,308
-140
| -10% | -$10.9K |
|
196
Coupang
CPNG
$27.8B
| $92K | 0.05% |
5,413
-923
| -15% | -$16.6K |
|
197
BorgWarner
BWA
$13.2B
| $90.7K | 0.05% |
2,246
-571
| -20% | -$24.2K |
|
198
Carnival Corporation Ltd
CCL
$36.1B
| $90.5K | 0.05% |
6,597
-1,125
| -15% | -$18.6K |
|
199
Mercado Libre
MELI
$91.3B
| $90K | 0.05% |
71
-12
| -14% | -$15.3K |
|
200
Royal Caribbean
RCL
$78.7B
| $87K | 0.05% |
944
-161
| -15% | -$16.1K |
|
Similar funds
AIS
IVGAI
OIM
TIP
RCG
CWM
SPW
WLC
AlphaCentric Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, AlphaCentric Advisors held 256 positions worth $176M, down 2.2% from $180M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
AlphaCentric Advisors deployed $11.2M of net new capital in Q3 2023, opening 24 new positions and adding to 39 existing holdings. Its largest new stake was Revance Therapeutics, Inc.: 190,000 shares worth $2.18M.
By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 60% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was Jazz Pharmaceuticals, an estimated $1.9M trimmed.
- AlphaCentric Advisors's largest Q3 2023 buy was Revance Therapeutics, Inc.: 190,000 shares worth $2.18M.
- AlphaCentric Advisors added most to Walgreens Boots Alliance in Q3 2023, an estimated $3.86M increase.
- AlphaCentric Advisors's biggest Q3 2023 reduction was Jazz Pharmaceuticals, cutting an estimated $1.9M.
- AlphaCentric Advisors fully exited AdaptHealth in Q3 2023, selling an estimated $3.44M.
- AlphaCentric Advisors's ten largest holdings make up 22% of its $176M portfolio in Q3 2023.
- AlphaCentric Advisors opened 24 new positions and closed 21 in Q3 2023.
- AlphaCentric Advisors's portfolio value fell 2.2% quarter-over-quarter to $176M.
Based on AlphaCentric Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.